Drug
Adjuvant Excipients
Adjuvant Excipients: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Adjuvant/Excipients NCT00806962 | Phase 1 | Norovirus |
Latest
No recent events.
Follow Adjuvant Excipients on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.